Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | LA |
Right knee Swollen; knee was very sore; This non-serious case was reported by a physician via call center representative and described the occurrence of swelling of knees in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 30-APR-2025, the patient received Shingrix (left arm). On 30-APR-2025, less than a day after receiving Shingrix, the patient experienced swelling of knees (Verbatim: Right knee Swollen) and knee pain (Verbatim: knee was very sore). The outcome of the swelling of knees was not resolved and the outcome of the knee pain was not reported. It was unknown if the reporter considered the swelling of knees and knee pain to be related to Shingrix. It was unknown if the company considered the swelling of knees and knee pain to be related to Shingrix. Additional Information: GSK Receipt Date: 30-APR-2025 The physician reported that he received a left arm shot of the medication Shingrix and by this morning, once the patient went to the swimming pool to exercise he noticed his right knee was swollen and very sore compared to the day before.